151 related articles for article (PubMed ID: 8607829)
41. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
42. Involvement of p27(kip1) and cyclin D3 in the regulation of cdk2 activity during skeletal muscle differentiation.
Chu CY; Lim RW
Biochim Biophys Acta; 2000 Jul; 1497(2):175-85. PubMed ID: 10903422
[TBL] [Abstract][Full Text] [Related]
43. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo.
Mantel C; Luo Z; Canfield J; Braun S; Deng C; Broxmeyer HE
Blood; 1996 Nov; 88(10):3710-9. PubMed ID: 8916935
[TBL] [Abstract][Full Text] [Related]
44. The amino terminus of Cdk2 binds p21.
Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
[TBL] [Abstract][Full Text] [Related]
45. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
47. Interaction of cyclin-dependent kinase 2 and the Lyn tyrosine kinase in cells treated with 1-beta-D-arabinofuranosylcytosine.
Yuan ZM; Huang Y; Kraeft SK; Chen LB; Kharbanda S; Kufe D
Oncogene; 1996 Sep; 13(5):939-46. PubMed ID: 8806683
[TBL] [Abstract][Full Text] [Related]
48. Cloning and characterization of rat p27Kip1, a cyclin-dependent kinase inhibitor.
Nomura H; Sawada Y; Fujinaga K; Ohtaki S
Gene; 1997 Jun; 191(2):211-8. PubMed ID: 9218722
[TBL] [Abstract][Full Text] [Related]
49. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Brown NR; Noble ME; Endicott JA; Johnson LN
Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
[TBL] [Abstract][Full Text] [Related]
50. The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase.
Rank KB; Evans DB; Sharma SK
Biochem Biophys Res Commun; 2000 May; 271(2):469-73. PubMed ID: 10799321
[TBL] [Abstract][Full Text] [Related]
51. Molecular cloning and identification of two types of hamster cyclin-dependent kinases: cdk2 and cdk2L.
Noguchi E; Sekiguchi T; Yamashita K; Nishimoto T
Biochem Biophys Res Commun; 1993 Dec; 197(3):1524-9. PubMed ID: 8280171
[TBL] [Abstract][Full Text] [Related]
52. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.
Nakanishi M; Robetorye RS; Adami GR; Pereira-Smith OM; Smith JR
EMBO J; 1995 Feb; 14(3):555-63. PubMed ID: 7859744
[TBL] [Abstract][Full Text] [Related]
53. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.
Harris TE; Albrecht JH; Nakanishi M; Darlington GJ
J Biol Chem; 2001 Aug; 276(31):29200-9. PubMed ID: 11369759
[TBL] [Abstract][Full Text] [Related]
54. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
Poon RY
Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
[No Abstract] [Full Text] [Related]
55. Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
Card GL; Knowles P; Laman H; Jones N; McDonald NQ
EMBO J; 2000 Jun; 19(12):2877-88. PubMed ID: 10856233
[TBL] [Abstract][Full Text] [Related]
56. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
Kaldis P; Cheng A; Solomon MJ
J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
[TBL] [Abstract][Full Text] [Related]
57. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
[TBL] [Abstract][Full Text] [Related]
58. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.
Poon RY; Hunter T
Science; 1995 Oct; 270(5233):90-3. PubMed ID: 7569954
[TBL] [Abstract][Full Text] [Related]
59. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2.
Ishimi Y; Komamura-Kohno Y; You Z; Omori A; Kitagawa M
J Biol Chem; 2000 May; 275(21):16235-41. PubMed ID: 10748114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
